chr6-35214431-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_152753.4(SCUBE3):​c.13C>A​(p.Arg5Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000757 in 1,321,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R5C) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.6e-7 ( 0 hom. )

Consequence

SCUBE3
NM_152753.4 missense

Scores

2
1
15

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.802

Publications

0 publications found
Variant links:
Genes affected
SCUBE3 (HGNC:13655): (signal peptide, CUB domain and EGF like domain containing 3) This gene encodes a member of the signal peptide, complement subcomponents C1r/C1s, Uegf, bone morphogenetic protein-1 and epidermal growth factor-like domain containing protein family. Overexpression of this gene in human embryonic kidney cells results in secretion of a glycosylated form of the protein that forms oligomers and tethers to the cell surface. This gene is upregulated in lung cancer tumor tissue compared to healthy tissue and is associated with loss of the epithelial marker E-cadherin and with increased expression of vimentin, a mesenchymal marker. In addition, the protein encoded by this gene is a transforming growth factor beta receptor ligand, and when secreted by cancer cells, it can be cleaved in vitro to release the N-terminal epidermal growth factor-like repeat domain and the C-terminal complement subcomponents C1r/C1s domain. Both the full length protein and C-terminal fragment can bind to the transforming growth factor beta type II receptor to promote the epithelial-mesenchymal transition and tumor angiogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
SCUBE3 Gene-Disease associations (from GenCC):
  • short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.145028).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152753.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCUBE3
NM_152753.4
MANE Select
c.13C>Ap.Arg5Ser
missense
Exon 1 of 22NP_689966.2
SCUBE3
NM_001303136.2
c.13C>Ap.Arg5Ser
missense
Exon 1 of 22NP_001290065.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCUBE3
ENST00000274938.8
TSL:1 MANE Select
c.13C>Ap.Arg5Ser
missense
Exon 1 of 22ENSP00000274938.7Q8IX30-1
SCUBE3
ENST00000889524.1
c.13C>Ap.Arg5Ser
missense
Exon 1 of 23ENSP00000559583.1
SCUBE3
ENST00000940915.1
c.13C>Ap.Arg5Ser
missense
Exon 1 of 23ENSP00000610974.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
94020
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.57e-7
AC:
1
AN:
1321096
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
652148
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
27516
American (AMR)
AF:
0.0000367
AC:
1
AN:
27278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23396
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28998
South Asian (SAS)
AF:
0.00
AC:
0
AN:
72258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37134
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4034
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1046156
Other (OTH)
AF:
0.00
AC:
0
AN:
54326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000905
AC:
1

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.086
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.045
T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.62
T
M_CAP
Pathogenic
0.38
D
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.80
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.050
N
REVEL
Benign
0.16
Sift
Benign
0.28
T
Sift4G
Benign
0.37
T
Polyphen
0.0
B
Vest4
0.23
MutPred
0.41
Gain of glycosylation at R5 (P = 0.0567)
MVP
0.33
MPC
0.89
ClinPred
0.51
D
GERP RS
3.0
PromoterAI
0.14
Neutral
Varity_R
0.15
gMVP
0.52
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757138761; hg19: chr6-35182208; API